China's Next Round Of Drug Price Cuts? NDRC To Slash Prices On More Products On National Drug Reimbursement List
This article was originally published in PharmAsia News
Executive SummarySHANGHAI - China's New Drug Price Guidelines are expected to be released by the end of this year, which are likely to lead to another round of price cuts on drugs included on the National Drug Reimbursement List, according to analysts
You may also be interested in...
China’s National Development and Reform Commission Dec. 2 releases new regulation on drug price differentiation intended to close loopholes.